Identity
- Trade Name
- MULTI-SPEECH FDA UDI
- Generic Name
- Voice amplification system FDA UDI
- Device Name
- Multi-Speech Microphone, Condensor FDA UDI
- Model / Reference
- 3706 FDA UDI
- Description
- Multi-Speech Microphone, Condensor FDA UDI
Identifiers
- Primary DI / UDI-DI
- 04961333230006 FDA UDI
- FDA Product Code
- KLX FDA UDI
- GMDN Term
- Voice amplification system FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 874.1325 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Voice amplification system
Multi-Speech by PENTAX of America, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Voice amplification system.
- Blom-Singer — FOUNTAIN HEAD MARKETING INC · Class I
- MemGuide — DSM BIOMEDICAL, INC. · Class II
- Romet — FOUNTAIN HEAD MARKETING INC · Class I
- SPEAX Patch for Home Use — ATAIA INC. · Class II
- SPEAX Digital Communicator Subscription Package — ATAIA INC. · Class II
- SPEAX Digital Communicator Trial Package — ATAIA INC. · Class II
- SPEAX Patch — ATAIA INC. · Class II
- Romet — FOUNTAIN HEAD MARKETING INC · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- PENTAX of America, Inc.
Sources (1)
- FDA UDI b46e0901-2779-4e7a-aabd-d7cd5658aa5e 33 fields · synced Jun 8, 2026